Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with a reduction of oxidative stress and inflammation in patients with type 2 diabetes mellitus

被引：0
|
作者：
von Bibra, H.
Diamant, M.
Scheffer, P.
Siegmund, T.
Schumm-Draeger, P.-M.
机构：
[1] Acad Hosp Bogenhausen, Munich, Germany
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1204
引用
收藏
页码：S493 / S493
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone, but not glimepiride, improves myocardial diastolic function and reduces oxidative stress in type 2 diabetic patients
    Von Bibra, H.
    Siegmund, T.
    Scheffer, P. G.
    Diamant, M.
    Schumm-Draeger, P. -M.
    EUROPEAN HEART JOURNAL, 2007, 28 : 459 - 460
  • [2] Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
    von Bibra, Helene
    Diamant, Michaela
    Scheffer, Peter G.
    Siegmund, Thorsten
    Schumm-Draeger, Petra-Maria
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (04): : 310 - 318
  • [3] Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus
    Kelly, Aaron S.
    Thelen, Andrea M.
    Kaiser, Daniel R.
    Gonzalez-Campoy, J. Michael
    Bank, Alan J.
    VASCULAR MEDICINE, 2007, 12 (04) : 311 - 318
  • [4] Rosiglitazone improves diastolic myocardial dysfunction compared to glimipiride in patients with type 2 diabetes mellitus
    Von Bibra, Helene
    Schumm-Draeger, Petra-Maria
    Siegmund, Thorsten
    DIABETES, 2007, 56 : A587 - A587
  • [5] Rosiglitazone improves diastolic myocardial dysfunction in patients with type 2 diabetes Aitus
    von, Bibra H.
    Siegmund, T.
    Schumm-Draeger, P. M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S23 - S24
  • [6] Compares effects of Glimepiride and Rosiglitazone on dysglycemia and oxidative stress of type 2 diabetes
    Monnier, L.
    Colette, C.
    Boegner, C.
    Michel, F.
    Nachbaur, G.
    Comenducci, A.
    DIABETES & METABOLISM, 2009, 35 : A60 - A60
  • [7] Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function
    Miguel Roman-Pintos, Luis
    Villegas-Rivera, Geannyne
    Daniel Rodriguez-Carrizalez, Adolfo
    Guillermina Miranda-Diaz, Alejandra
    German Cardona-Munoz, Ernesto
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [8] Association between rosiglitazone use and decline in renal function in patients with type 2 diabetes mellitus
    Feldman, Leonid
    Shani, Michal
    Efrati, Shai
    Beberashvili, Ilia
    Baevsky, Tuvia
    Weissgarten, Joshua
    Vinker, Shlomo
    JOURNAL OF NEPHROLOGY, 2010, 23 (03) : 350 - 356
  • [9] Effects of rosiglitazone versus glyburide on endothelial function and oxidative stress in patients with type 2 diabetes
    Kelly, Aaron S.
    Thelen, Andrea M.
    Kaiser, Daniel R.
    Bank, Alan J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 401A - 401A
  • [10] Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus Prevalence and Association With Myocardial and Vascular Disease
    Poulsen, Mikael Kjaer
    Henriksen, Jan Erik
    Dahl, Jordi
    Johansen, Allan
    Gerke, Oke
    Vach, Werner
    Haghfelt, Torben
    Hoilund-Carlsen, Poul Flemming
    Beck-Nielsen, Henning
    Moller, Jacob Eifer
    CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (01) : 24 - 31
12345